Laser Research Centre, University of Johannesburg, Johannesburg, South Africa.
J Wound Care. 2022 Oct 2;31(10):832-845. doi: 10.12968/jowc.2022.31.10.832.
Current therapies and technologies used to treat hard-to-heal diabetic wounds are limited to a 50% healing rate. The rise in the percentage of lower limb non-traumatic amputations in patients with diabetes has caused an increased demand for alternative, effective and safe treatment modalities. Photobiomodulation therapy (PBMT) utilises light to induce physiological changes and provide therapeutic benefits and has been shown to increase the healing of hard-to-heal wounds through the release of growth factors. The aim of this narrative review is to investigate the effect of photobiomodulation (PBM) on fibroblast growth factor (FGF) and the role of the Ras/MAPK signalling pathway in diabetic wound healing.
Relevant journal articles were obtained through PubMed and Google Scholar.
Experimental and clinical findings from the review show that PBM can stimulate the release of growth factors, including FGF, an essential cytokine in wound healing, and one which is present at lower concentrations in diabetic wounds. There is also activation of the Ras/MAPK signalling pathway.
One mechanism through which healing may be stimulated by PBM is via the FGF-Ras/MAPK signalling pathway, although strong evidence under hyperglycaemic conditions is lacking.
目前用于治疗难治性糖尿病创面的疗法和技术的愈合率仅为 50%。糖尿病患者下肢非创伤性截肢率的上升,导致对替代、有效和安全的治疗方法的需求增加。光生物调节疗法(PBMT)利用光来诱导生理变化并提供治疗益处,并已被证明通过释放生长因子来增加难治性创面的愈合。本叙述性综述的目的是研究光生物调节(PBM)对成纤维细胞生长因子(FGF)的影响,以及 Ras/MAPK 信号通路在糖尿病创面愈合中的作用。
通过 PubMed 和 Google Scholar 获取相关的期刊文章。
综述的实验和临床结果表明,PBM 可以刺激生长因子的释放,包括 FGF,这是创面愈合中必不可少的细胞因子,而在糖尿病创面中其浓度较低。Ras/MAPK 信号通路也被激活。
尽管在高血糖条件下缺乏强有力的证据,但 PBM 可能通过 FGF-Ras/MAPK 信号通路刺激愈合的一种机制。